-
Subject Areas on Research
-
A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes.
-
A Cost Analysis of Universal versus Targeted Cholesterol Screening in Pediatrics.
-
A review of cardiovascular risk factors in US military personnel.
-
A sex-specific relationship between capillary density and anaerobic threshold.
-
Aerobic and resistance training effects on energy intake: the STRRIDE-AT/RT study.
-
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial.
-
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.
-
Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C.
-
Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor.
-
Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.
-
Association of comorbidity burden with abnormal cardiac mechanics: findings from the HyperGEN study.
-
Associations of ABCB1 and IL-10 genetic polymorphisms with sirolimus-induced dyslipidemia in renal transplant recipients.
-
Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
-
Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.
-
Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial.
-
Behavioral health mediators of the link between posttraumatic stress disorder and dyslipidemia.
-
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
-
Beverage Consumption and Longitudinal Changes in Lipoprotein Concentrations and Incident Dyslipidemia in US Adults: The Framingham Heart Study.
-
Branched-chain amino acids in disease.
-
Cardiometabolic Risk Factors among Severely Obese Children and Adolescents in the United States, 1999-2012.
-
Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study.
-
Cardiovascular complications of diabetic kidney disease.
-
Cardiovascular health knowledge and preventive practices in people living with HIV in Kenya.
-
Care continuity impacts medicare expenditures of older adults: Fact or fiction?
-
Characteristics of pediatric cardiovascular clinical trials registered on ClinicalTrials.gov.
-
Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome.
-
Communicating health information and improving coordination with primary care (CHIIP): Rationale and design of a randomized cardiovascular health promotion trial for adult survivors of childhood cancer.
-
Comparison of Nonblood-Based and Blood-Based Total CV Risk Scores in Global Populations.
-
Cross-sectional relations of lipid concentrations to left ventricular structural attributes.
-
Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.
-
Dietary carbohydrate intake and high-sensitivity C-reactive protein in at-risk women and men.
-
Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers.
-
Discordances between predicted and actual risk in obese patients with suspected cardiac ischaemia.
-
Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial.
-
Effect of exercise intensity and volume on persistence of insulin sensitivity during training cessation.
-
Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer.
-
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease.
-
Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs.
-
Ethnic variation in the impact of metabolic syndrome components and chronic kidney disease.
-
Fibrate use in the United States and Canada.
-
Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects ≥65 Years.
-
From the editor: From a hell of a year to "Hello Telemedicine".
-
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
-
Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
-
Greater weight loss with increasing age in the weight loss maintenance trial.
-
Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get with the Guidelines-Stroke 2003 to 2012.
-
Impact of 5-year weight change on blood pressure: results from the Weight Loss Maintenance trial.
-
Impact of Heart Outcomes Prevention Evaluation Trial on Statin Eligibility for the Primary Prevention of Cardiovascular Disease: Insights from the National Health and Nutrition Examination Survey.
-
Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics.
-
In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABG.
-
Inactivity, exercise, and visceral fat. STRRIDE: a randomized, controlled study of exercise intensity and amount.
-
Inherited lipemic splenomegaly and the spectrum of apolipoprotein E p.Leu167del mutation phenotypic variation.
-
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
-
Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment.
-
Lifetime risk for developing dyslipidemia: the Framingham Offspring Study.
-
Lipid Testing and Statin Dosing After Acute Myocardial Infarction.
-
Lipid profiles of pediatric hematopoietic stem cell transplant survivors.
-
Lipids and bariatric procedures Part 2 of 2: scientific statement from the American Society for Metabolic and Bariatric Surgery (ASMBS), the National Lipid Association (NLA), and Obesity Medicine Association (OMA).
-
Lipids and diabetic retinopathy.
-
Lipids in high-risk patients presenting with ischemic stroke or transient ischemic attack: are we missing the target?
-
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline.
-
Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus.
-
Management of dyslipidemia in children and adolescents with systemic lupus erythematosus.
-
Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure: A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya.
-
Medication Discontinuation in the IMPROVE-IT Trial.
-
Metabolic syndrome and risk of age-related macular degeneration.
-
Metabolic syndrome components and age-related cataract: the Singapore Malay eye study.
-
MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.
-
Niacin and heart disease prevention: Engraving its tombstone is a mistake.
-
Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.
-
Obesity and risk for hypertension and diabetes among Kenyan adults: Results from a national survey.
-
PCSK9 Inhibitor Use in the Real World: Data From the National Patient-Centered Research Network.
-
Patient perspectives on having multiple versus single prescribers of chronic disease medications: results of a qualitative study in a veteran population.
-
Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial.
-
Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection.
-
Prescriber Continuity and Disease Control of Older Adults.
-
Prescriber continuity and medication adherence for complex patients.
-
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.
-
Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey.
-
Prevention of future cardiovascular disease in high-risk pediatric patients: a role for lipid lowering therapy?
-
Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.
-
Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trial.
-
Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and visceral adiposity.
-
Retinal vascular caliber, blood pressure, and cardiovascular risk factors in an Asian population: the Singapore Malay Eye Study.
-
Retinal vascular manifestations of metabolic disorders.
-
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
-
Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study.
-
Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH database.
-
Sex Differences in the Use of Statins in Community Practice.
-
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
-
Statins in adult patients with HIV: Protocol for a systematic review and network meta-analysis.
-
Study protocol: Couples Partnering for Lipid Enhancing Strategies (CouPLES) - a randomized, controlled trial.
-
The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study.
-
The editor's roundtable: Closing the clinical practice gap-using evidence-based treatments for managing lipids.
-
The effects of aerobic, resistance, and combination training on insulin sensitivity and secretion in overweight adults from STRRIDE AT/RT: a randomized trial.
-
The relationship between the blood pressure responses to exercise following training and detraining periods.
-
Underdiagnosis and Undertreatment of Modifiable Cardiovascular Risk Factors Among Survivors of Childhood Cancer.
-
Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor Initiation.
-
Weight and Metabolic Outcomes 12 Years after Gastric Bypass.
-
What Defines a Valuable Investment in Global Health Research?
-
Keywords of People